1314394-96-1 Usage
Molecular structure
2-(tert-butoxycarbonyl)hexahydrocyclopenta[c]pyrrole-3a(1H)-carboxylic acid has a complex molecular structure that includes a cyclopentane ring fused to a pyrrole ring, and a tert-butoxycarbonyl group attached to the nitrogen atom.
Chemical class
2-(tert-butoxycarbonyl)hexahydrocyclopenta[c]pyrrole-3a(1H)-carboxylic acid belongs to the class of carboxylic acids.
Function as a protecting group
It is commonly used in organic synthesis as a protecting group for amines, which helps prevent unwanted side reactions during chemical reactions.
Potential pharmaceutical applications
Due to its unique structural features, 2-(tert-butoxycarbonyl)hexahydrocyclopenta[c]pyrrole-3a(1H)-carboxylic acid has potential applications in the pharmaceutical industry.
Importance in chemical synthesis
The compound's synthesis and utilization in various chemical reactions make it an important intermediate in the production of pharmaceuticals and other organic compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1314394-96-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,1,4,3,9 and 4 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1314394-96:
(9*1)+(8*3)+(7*1)+(6*4)+(5*3)+(4*9)+(3*4)+(2*9)+(1*6)=151
151 % 10 = 1
So 1314394-96-1 is a valid CAS Registry Number.
1314394-96-1Relevant articles and documents
Bicyclic Pyrrolidines for Medicinal Chemistry via [3 + 2]-Cycloaddition
Chalyk, Bohdan A.,Hryshchuk, Oleksandr V.,Isakov, Andrii O.,Kovalenko, Dmytro V.,Melnychuk, Pavlo V.,Mykhailiuk, Pavel K.,Mykhalchuk, Vladimir L.,Pavlenko, Sergiy O.,Reznik, Vitalii A.,Rusanov, Eduard B.,Savchuk, Taras,Savych, Vladimir I.,Siry, Sergiy A.,Timoshenko, Vadim M.,Yarmolchuk, Vladimir S.
, p. 13289 - 13309 (2021/09/13)
A general approach to bicyclic fused pyrrolidines via [3 + 2]-cycloaddition between nonstabilized azomethyne ylide and endocyclic electron-deficient alkenes was elaborated. Push-pull alkenes and CF3-alkenes did not react with the azomethyne ylide under the previously reported conditions, and we developed a superior protocol (LiF, 140 °C, no solvent). Among obtained products were medchem-relevant bicyclic sulfones, monofluoro-, difluoro-, and trifluoromethyl-substituted pyrrolidines. This approach not only allowed preparation of novel molecules but also significantly simplified synthesis of the existing ones (e.g., sofinicline).
